Overview
Farah Al Haj is a Hematologist practicing medicine in Detroit, Michigan.
Her clinical expertise encompasses Leukocytosis.
She is actively involved in clinical research, co-authoring 1 peer reviewed article.
Specialties
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
6071 W Outer Dr, Detroit, MI 48235
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Karmanos Cancer Center
Jeffrey Zonder is a Hematologist practicing medicine in Detroit, Michigan. Dr. Zonder is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Vertebroplasty. Dr. Zonder is currently accepting new patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
Karmanos Cancer Center
Voravit Ratanatharathorn is a Hematologist practicing medicine in Detroit, Michigan. Dr. Ratanatharathorn is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. Ratanatharathorn is currently accepting new patients.
Frequently Asked Questions about Dr. Farah M. Al Haj
How do I make an appointment with Dr. Farah M. Al Haj?
You can book an appointment with Dr. Farah M. Al Haj by calling their office at 313-966-4807. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Farah M. Al Haj a top-rated expert for Leukocytosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Farah M. Al Haj is classified as an Experienced expert for Leukocytosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Farah M. Al Haj specialize in?
While Dr. Farah M. Al Haj is a Hematology, they have specific expertise in Leukocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Farah M. Al Haj participate in research or clinical trials?
Yes. Dr. Farah M. Al Haj has published 1 articles and abstracts on conditions like Leukocytosis. You can view a list of Dr. Farah M. Al Haj's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Farah M. Al Haj accept my insurance?
Dr. Farah M. Al Haj accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 313-966-4807 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers